clinicaltrials gov 5 amino 1mq 5-AMINO-1MQ VIAL (5MG) Peptide Therapy - 5-Amino-1MQ –
Description
AOD-9604 has superior plasma stability (longer half-life) and is the only fragment that completed Phase 2b clinical trials in obesity
In a clinical setting, vitamin B12 injections are rarely administered on a per day basis for long-term maintenance
The best time to take AOD 9604 is in the morning and on an empty stomach, ideally 3060 minutes before your first meal
In preclinical research, 5-Amino-1MQ is primarily investigated for its ability to inhibit NNMT activity, which may influence multiple interconnected metabolic pathways
